At the end the 9 months test period were 66 % of the patients catheter-free ‘protocol-defined treatment failure ‘of, compared to 16 % of patients treated with drugs .
This information was of kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation , you can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for. E-mail delivery to kaiser health news.The research was a cooperation between researchers at Institute of Cancer Research, United Kingdom, the Samuel Lunenfeld research Institute, Mt of the Sinai Hospital, in Toronto, the University of Toronto, and the University of California, San Francisco.
Sinapis Pharma a IND approval from the FDASinapis pharmaceutical is delighted to announce that received evidence by the FDA that their Investigational New Drug Application has been authorized to the use of IV methamphetamine for acute ischemic stroke 9 April 2010. lots of work a lot of work for a small organization at a very tight budget. We have GMP medicine ready period phase I clinical trial and which stage I site to begin to begin, said Dr. Donald Picker, the chief executive officer. After completion of the Phase I study , the company will to treat with the FDA on a protocol to caress victims and consent begin Your proof of principle clinical trial with the world’s leading stroke clinicians designing and execution of the program.